- Home
- IMCC vs RDHL Comparison
IMCC vs RDHL Comparison
Compare IMCC & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- RDHL
- Stock Information
- Founded
- IMCC 1980
- RDHL 2009
- Country
- IMCC Israel
- RDHL Israel
- Employees
- IMCC N/A
- RDHL N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- RDHL Health Care
- Exchange
- IMCC Nasdaq
- RDHL Nasdaq
- Market Cap
- IMCC 10.0M
- RDHL 4.3M
- IPO Year
- IMCC N/A
- RDHL N/A
- Fundamental
- Price
- IMCC $2.91
- RDHL $2.02
- Analyst Decision
- IMCC
- RDHL
- Analyst Count
- IMCC 0
- RDHL 0
- Target Price
- IMCC N/A
- RDHL N/A
- AVG Volume (30 Days)
- IMCC 147.9K
- RDHL 19.3K
- Earning Date
- IMCC 08-13-2025
- RDHL 08-28-2025
- Dividend Yield
- IMCC N/A
- RDHL N/A
- EPS Growth
- IMCC N/A
- RDHL N/A
- EPS
- IMCC N/A
- RDHL N/A
- Revenue
- IMCC $37,894,737.00
- RDHL $8,042,999.00
- Revenue This Year
- IMCC $47.12
- RDHL $381.91
- Revenue Next Year
- IMCC $12.83
- RDHL N/A
- P/E Ratio
- IMCC N/A
- RDHL N/A
- Revenue Growth
- IMCC 12.68
- RDHL 23.17
- 52 Week Low
- IMCC $1.29
- RDHL $1.71
- 52 Week High
- IMCC $7.12
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- IMCC 55.33
- RDHL 57.04
- Support Level
- IMCC $2.37
- RDHL $1.75
- Resistance Level
- IMCC $2.95
- RDHL $2.08
- Average True Range (ATR)
- IMCC 0.42
- RDHL 0.10
- MACD
- IMCC -0.03
- RDHL 0.03
- Stochastic Oscillator
- IMCC 56.93
- RDHL 85.16
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.